No association between IL-1β -31 C/T polymorphism and the risk of duodenal ulcer: A meta-analysis of 3793 subjects

Human Immunology

Volumn 73, Issue 11, 2012, Pages 1200-1206

  Zhang, Bei Bei ^a   Wang, Juan ^b   Bian, Dong Ling ^a   Chen, Xiao Yan ^a  

^a General Hospital of PLA Chengdu Military Area Command   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA;

ALLELE; ARTICLE; DNA POLYMORPHISM; DUODENUM ULCER; ETHNIC DIFFERENCE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HELICOBACTER INFECTION; HUMAN; INTERRATER RELIABILITY; META ANALYSIS; PRIORITY JOURNAL; PUBLISHING; REFERENCE DATABASE; SYSTEMATIC REVIEW;

ALLELES; DUODENAL ULCER; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-1BETA; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS;

EID: 84867890241     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.08.006     Document Type: Article

References (40)

1. Go M.F. Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther 2002, 16:3-15.
2. Stadtländer C.T., Waterbor J.W. Molecular epidemiology, pathogenesis and prevention of gastric cancer. Carcinogenesis 1999, 20:2195-2208.
3. Taylor D.N., Blaser M.J. The epidemiology of Helicobacter pylori infection. Epidemiol Rev 1991, 13:42-59.
4. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 1996, 87:2095-2147.
5. Robert A., Olafsson A.S., Lancaster C., Zhang W.R. Interleukin-1 is cytoprotective, antisecretory, stimulates PGE2 synthesis by the stomach, and retards gastric emptying. Life Sci 1991, 48:123-134.
6. Wallace J.L., Cucala M., Mugridge K., Parente L. Secretagogue-specific effects of interleukin-1 on gastric acid secretion. Am J Physiol 1991, 261:G559-G564.
7. Wolfe M.M., Nompleggi D.J. Cytokine inhibition of gastric acid secretion-a little goes a long way. Gastroenterology 1992, 102:2177-2178.
8. Beales I.L., Calam J. Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut 1998, 42:227-234.
9. Nicklin M.J., Weith A., Duff G.W. A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes. Genomics 1994, 19:382-384.
10. di Giovine F.S., Takhsh E., Blakemore A.I., Duff G.W. Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Hum Mol Genet 1992, 1:450.
11. Pociot F., Mølvig J., Wogensen L., Worsaae H., Nerup J. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 1992, 22:396-402.
12. Hwang I.R., Kodama T., Kikuchi S., Sakai K., Peterson L.E., Graham D.Y., et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 2002, 123:1793-1803.
13. Zhang B.B., Yin Y.W., Sun Q.Q. No association between IL-1β -511 C/T polymorphism and the risk of duodenal ulcer: a meta-analysis of 4667 subjects. Gene 2012, 10.1016/j.gene.2012.06.05.
14. Furuta T., El-Omar E.M., Xiao F., Shirai N., Takashima M., Sugimura H. Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 2002, 123:92-105.
15. Zambon C.F., Basso D., Navaglia F., Germano G., Gallo N., Milazzo M., et al. Helicobacter pylori virulence genes and host IL-1RN and IL-1beta genes interplay in favouring the development of peptic ulcer and intestinal metaplasia. Cytokine 2002, 18:242-251.
16. Lee S.G., Kim B., Choi W., Lee I., Choi J., Song K. Lack of association between pro-inflammatory genotypes of the interleukin-1 (IL-1B -31 C/+ and IL-1RN *2/*2) and gastric cancer/duodenal ulcer in Korean population. Cytokine 2003, 21:167-171.
17. García-González M.A., Lanas A., Savelkoul P.H., Santolaria S., Benito R., Crusius J.B., et al. Association of interleukin 1 gene family polymorphisms with duodenal ulcer disease. Clin Exp Immunol 2003, 134:25-31.
18. Zambon C.F., Basso D., Navaglia F., Belluco C., Falda A., Fogar P., et al. Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine 2005, 29:141-152.
19. Garcia-Gonzalez M.A., Savelkoul P.H., Benito R., Santolaria S., Crusius J.B., Peña A.S., et al. No allelic variant associations of the IL-1 and TNF gene polymorphisms in the susceptibility to duodenal ulcer disease. Int J Immunogenet 2005, 32:299-306.
20. Queiroz D.M., Bittencourt P., Guerra J.B., Rocha A.M., Rocha G.A., Carvalho A.S. IL1RN polymorphism and cagA-positive Helicobacter pylori strains increase the risk of duodenal ulcer in children. Pediatr Res 2005, 58:892-896.
21. Chakravorty M., Ghosh A., Choudhury A., Santra A., Hembrum J., Roychoudhury S. Interaction between IL1B gene promoter polymorphisms in determining susceptibility to Helicobacter pylori associated duodenal ulcer. Hum Mutat 2006, 27:411-419.
22. Sugimoto M., Furuta T., Shirai N., Nakamura A., Xiao F., Kajimura M., et al. Different effects of polymorphisms of tumor necrosis factor-alpha and interleukin-1 beta on development of peptic ulcer and gastric cancer. J Gastroenterol Hepatol 2007, 22:51-59.
23. Erzin Y., Koksal V., Altun S., Dobrucali A., Aslan M., Erdamar S., et al. Role of host interleukin 1beta gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in clinical outcomes in Helicobacter pylori-positive Turkish patients with dyspepsia. J Gastroenterol 2008, 43:705-710.
24. Shin W.G., Jang J.S., Kim H.S., Kim S.J., Kim K.H., Jang M.K., et al. Polymorphisms of interleukin-1 and interleukin-2 genes in patients with gastric cancer in Korea. J Gastroenterol Hepatol 2008, 23:1567-1573.
25. Melo Barbosa H.P., Martins L.C., Dos Santos S.E., Demachki S., Assumpção M.B., Aragão C.D., et al. Interleukin-1 and TNF-alpha polymorphisms and Helicobacter pylori in a Brazilian Amazon population. World J Gastroenterol 2009, 15:1465-1471.
26. Moher D., Liberati A., Tetzlaff J. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009, 151:264-269.
27. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Health Research Institute. (accessed Dec. 1, 2011). http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
28. Lewis C.M. Genetic association studies: design, analysis and interpretation. Brief Bioinform 2002, 3:146-153.
29. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959, 22:719-748.
30. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
31. Cochran W.G. The combination of estimates from different experiments. Biometrics 1954, 10:101-129.
32. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
33. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
34. Robert A., Saperas E., Zhang W.R., Olafsson A.S., Lancaster C., Tracey D.E., et al. Gastric cytoprotection by intracisternal interleukin-1 beta in the rat. Biochem Biophys Res Commun 1991, 174:1117-1124.
35. Noach L.A., Bosma N.B., Jansen J., Hoek F.J., van Deventer S.J., Tytgat G.N. Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol 1994, 29:425-429.
36. Lindholm C., Quiding-Järbrink M., Lönroth H., Hamlet A., Svennerholm A.M. Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun 1998, 66:5964-5971.
37. Yann-Jinn Lee, Chi-Yu Huang, Wei-Hsin Ting, Wen-Ling Guo, Wei-Fang Chen, Chiung-Ling Lin, et al. Association of an IL-4 gene haplotype with Graves disease in children: experimental study and meta-analysis. Human Immunology 2011, 72:256-261.
38. Mercedes Garcîa-Bermûdez, Raquel Lôpez-Mejias, Luis Rodriguez-Rodriguez, Benjamîn Fernândez-Gutierrez, Antonio Garcîa, Enrique Raya, Ana M. Ortiz, Marieke J.H. Coenen, Piet L.C.M. van Riel, Timothy R.D.J. Radstake, Javier Martîn, No evidence of association of the KLF12 gene with rheumatoid arthritis in Spanish and Dutch cohorts and a meta-analysis of published data, Human Immunology 2011; 72: 779-82.
39. Koletzko S., Ashorn M. Paediatrics. Curr Opin Gastroenterol 1998, 14:S57-S63.
40. Blaser M.J., Chyou P.H., Nomura A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res 1995, 55:562-565.